{"id":"W4415940248","doi":"10.1016/j.annonc.2025.08.3216","title":"2600MO Relevance of the CPS score and tumor nephrectomy in the SUNNIFORECAST trial comparing ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"EMD Serono; Ipsen; European Society for Medical Oncology; Astellas Pharma; Eisai; European Association of Urology; Micropalaeontological Society; National Cancer Institute; Aptitude Health; Bamfield Marine Sciences Centre; Cleveland Clinic; Daiichi Sankyo Europe; Exelixis; Eli Lilly and Company; AstraZeneca; American Society of Clinical Oncology; Institut Gustave-Roussy; Invitae; Gilead Sciences; Amgen; Dana-Farber Cancer Institute; Pfizer; Society for Immunotherapy of Cancer","keywords":"Standard of care; Nephrectomy; Renal cell carcinoma; Clinical trial; Immunotherapy; Kidney cancer; Cell; MEDLINE","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001406336,0.0007182724,0.001970048,0.0002310645,0.0003133245,0.001231865,0.0005356493,0.0007688492,0.003904628],"category_scores_gemma":[0.001751912,0.0002911135,0.002851371,0.0002439968,0.0006209837,0.0008354548,0.0004066748,0.002629052,0.0003562378],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009009367,"about_ca_system_score_gemma":0.000929369,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001258039,"about_ca_topic_score_gemma":0.003410344,"domain_scores_codex":[0.9993253,0.0003551626,0.00003950838,0.0001189679,0.00006542468,0.00009565501],"domain_scores_gemma":[0.9993249,0.0002285798,0.0001450865,0.00004853359,0.00004858685,0.000204259],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9396427,0.001630137,0.00761284,0.0008266371,0.005875402,0.00003855609,0.00003831172,0.001093154,0.001622892,0.0003297718,0.001888078,0.03940153],"study_design_scores_gemma":[0.7061871,0.1710966,0.0884738,0.0004673978,0.01519601,0.0001991171,0.0001790135,0.006133891,0.002289295,0.002106244,0.007568304,0.0001034013],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9831345,0.009231642,0.0002997854,0.001110648,0.001009113,0.0002919926,0.0006903664,0.00004392641,0.004188091],"genre_scores_gemma":[0.9949178,0.001210543,0.000287535,0.0005500446,0.0004661615,0.0001456473,0.0007706196,0.000008837472,0.001642883],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003904628,"threshold_uncertainty_score":0.0130623,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06202969745579245,"score_gpt":0.3550135299256223,"score_spread":0.2929838324698298,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}